Price
Target price
€22.20
€22.20
0.000%
-
0.000%
€39.57
08:21 / Tradegate
WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Agios Pharmaceuticals Inc. Stock
The Agios Pharmaceuticals Inc. price is unchanged compared to yesterday.
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Agios Pharmaceuticals Inc..
As a result the target price of 39 € shows a very positive potential of 75.68% compared to the current price of 22.2 € for Agios Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Agios Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | 0.000% | -25.503% | -8.264% | -9.756% | -4.310% | 5.714% | -51.412% |
| Ligand Pharmaceuticals | 1.020% | 3.158% | 13.953% | 109.626% | 18.072% | 182.014% | 62.050% |
| United Therapeutics | -0.120% | -0.507% | 9.273% | 89.266% | 14.720% | 133.317% | 180.114% |
| Ionis Pharmaceuticals Inc. | -1.250% | -2.581% | 4.035% | 146.866% | -6.680% | 92.357% | 79.609% |
Comments
Agios Pharmaceuticals (AGIO) had its price target lowered by Bank of America Corporation from $44.00 to $41.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (AGIO) had its price target lowered by HC Wainwright from $65.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (AGIO) had its price target raised by Citigroup Inc. from $38.00 to $46.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
News
Here's Why Agios Pharmaceuticals Crashed 23% Today
Shares in Agios Pharmaceuticals (NASDAQ: AGIO) slumped by 23% as of 11 a.m. today. As is often the case with small-cap healthcare stocks, the move isn't so much dictated by what the company is doing
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today
Drugmaker Agios Pharmaceuticals (NASDAQ: AGIO) is positioning to win the FDA's approval of its mitapivat as a treatment for sickle cell disease sooner than investors may have been expecting.
That's
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything
Viswanadhan Krishnan, Chief Corporate Development and Strategy Officer at Agios Pharmaceuticals (NASDAQ:AGIO), reported the open-market sale of 2,959 shares of common stock for a total of roughly